¥2,130.00
1.25%
Tokyo, Sep 28, 02:48 pm JST. Closed.
ISIN
JP3119660003
Symbol
4886

Aska Pharmaceutical Holdings Co.,ltd. Stock price

¥2,125.00
+8.00 0.38% 1M
-210.00 8.99% 6M
+87.00 4.27% YTD
-201.00 8.64% 1Y
+395.00 22.83% 3Y
+1,065.00 100.47% 5Y
+309.58 17.05% 10Y
+1,096.60 106.63% 20Y
Tokyo, Closing price Mon, Sep 28 2026
-32.00 1.48%
ISIN
JP3119660003
Symbol
4886
Industry

Is Aska Pharmaceutical Holdings Co.,ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
¥56.8b
Enterprise Value
¥61.6b
Net debt
¥4.7b
Cash
¥7.1b
Shares outstanding
28.4m
Valuation (TTM | estimate)
P/E
13.0
P/S
0.8 | 0.8
EV/Sales
0.9 | 0.8
EV/FCF
-
P/B
0.8
Dividends
DPS
¥65.00
Yield 1Y | 5Y
3.0% | 2.5%
Growth 1Y | 5Y
8.3% | 34.1%
Payout 1Y | 3Y
31.4% | 24.3%
Increased
8 Years
Financials (TTM | estimate)
Revenue
¥69.2b | ¥73.9b
EBITDA
-
EBIT
¥4.9b
Net Income
¥4.7b
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
3.1% | 3.8%
EBITDA
-
EBIT
-18.2%
Net Income
-7.1%
Free Cash Flow
-
Margin
Gross
48.6%
EBITDA
-
EBIT
7.1%
Net
6.8%
Free Cash Flow
-
Financial Health
Equity Ratio
62.6%
Return on Equity
7.7%
ROCE
5.5%
ROIC
4.5%
Debt/Equity
0.2
More
EPS
¥166.0
FCF per Share
-
Short interest
-
Employees
2k
Rev per Employee
¥43.6m

Aska Pharmaceutical Holdings Co.,ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Aska Pharmaceutical Holdings Co.,ltd. forecast:

3x Hold
43%
4x Sell
57%

Analyst Opinions

7 Analysts have issued a Aska Pharmaceutical Holdings Co.,ltd. forecast:

Hold
43%
Sell
57%

Financial data from Aska Pharmaceutical Holdings Co.,ltd.

Jun '26
+/-
%
69,190 69,190
3% 3%
100%
- Direct Costs 35,585 35,585
1% 1%
51%
33,605 33,605
6% 6%
49%
- Selling and Administrative Expenses 28,538 28,538
7% 7%
41%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 4,918 4,918
18% 18%
7%
Net Profit 4,713 4,713
7% 7%
7%

In millions JPY.

Don't miss a Thing! We will send you all news about Aska Pharmaceutical Holdings Co.,ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

ASKA Pharmaceutical Holdings Co., Ltd. engages in manufacture, sale, and import/export of medical drugs and other products. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 1,632 full-time employees. The company went IPO on 2021-04-01. The firm has three business segments. The Pharmaceutical Business segment primarily manufactures and sells prescription pharmaceuticals. The Animal Health Business segment primarily manufactures and sells veterinary medicines, feed additives, and other products. The Overseas Business segment primarily manufactures and sells prescription pharmaceuticals overseas. The firm also engages in clinical testing and medical equipment businesses.

Head office Japan
Employees 1,632
Website www.aska-pharma-hd.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today